Skip to main content
OpenTrials

Clinical trial condition

Residual, Progressive or Recurrent Grade II or III Meningioma

Explore clinical trials studying Residual, Progressive or Recurrent Grade II or III Meningioma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Residual, Progressive or Recurrent Grade II or III Meningioma trial results

NCT05023018

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sutter Health Research Institute San Francisco, California, United States
  • Saint John Cancer Institute Santa Monica, California, United States
  • Tufts Medical Center Boston, Massachusetts, United States